scholarly journals PHARMACEUTICAL MARKET AND OPPORTUNITY IN THE 21ST CENTURY FOR GENERIC DRUGS: A BRAZILIAN CASE STUDY OF OLANZAPINE

2013 ◽  
Vol 6 (1) ◽  
pp. 31-39
Author(s):  
Jorge Lima de Magalhães ◽  
Luc Quoniam ◽  
Núbia Boechat
Keyword(s):  
Pharmaceutical Industry ◽  
Generic Drugs ◽  
Innovation Management ◽  
Developing Nations ◽  
Pharmaceutical Market ◽  
Competitive Intelligence ◽  
Bibliographical Survey ◽  
Official Data ◽  
Total Market

This paper aimed to identify and analyse the evolution of the generic pharmaceutical market in Brazil, specifically olanzapine drugs. For this purpose, it has been demonstrated trends through access free tools. By bibliographical survey in indexed databases as well as official data in Brazil for generic drugs and public policy, it was analyzed and performed a case study . In 2012, global pharmaceutical industry surpassed US$ 950 billion in sales with trend to reach US$ 1,2 trillion by 2016. In Brazil market has grown in its global ranking, jumped from 10th place to 7th place in five years and projection it’ll stay Top five by 2015. Brazil has significant presence in pharmerging markets by increasing US$ 10 billion/year. Generics segment accounts approximately to 20% of the total market. 2003-2011 registered a growth of 42.3%. Patents expiration in the neuroleptics area becomes more promising like a market of olanzapine in the last eight years is around US$ 120 million. After the end of the olanzapine patent (2011) sales increased 270% which demonstrate potential Brazilian market in this new century. Management problems for developing nations and undeveloped such as network management and patents analysis for health care might reveal great opportunities for investors, e.g., creation of the Big Brazilian biotechnology pharmaceutical industry. Keywords: competitive intelligence, pharmaceutical trends, technological and innovation management.

KEY DIFFERENCES AND SIMILARITIES IN WAYS OF MANAGING AND SUPPORTING RADICAL PHARMACEUTICAL FRONT END INNOVATION — A CASE STUDY OF THE PHARMACEUTICAL INDUSTRY

2015 ◽  
Vol 19 (01) ◽  
pp. 1550011 ◽  
Author(s):  
ANNABETH AAGAARD
Keyword(s):  
Pharmaceutical Industry ◽  
Comparative Study ◽  
Innovation Management ◽  
Value Added ◽  
Pharmaceutical Companies ◽  
International Borders ◽  
Front End ◽  
Global Study ◽  
Similarities And Differences

The purpose of this paper is to explore how Front End Innovation (FEI) is supported and managed among companies of different nationality within the context of pharmaceutical R&D. The present study is carried out in order to contribute to the development of a clearer understanding of active facilitation of innovation management and FEI in theory and in practice across international borders. I aim to show how different aspects of Pharma and nationality affect the way innovation management and radical FEI are supported within organisations. This is examined through an in-depth case study of the Danish and US based pharmaceutical company, H. Lundbeck A/S, and a comparative study including five European and American pharmaceutical companies. The findings from the study reveal a number of similarities and differences in innovation management and FEI support of radical projects and among the different nationalities. This presents propositions of important aspects to consider in facilitation of radical FEI in general and in multinational pharmaceutical companies. In addition, proposals are made for a global study of innovation management and FEI support including Chinese and other Asian pharmaceutical companies, which represent a growing market. The value added and the contribution of this paper to the existing FEI literature is therefore in the specificity of the empirical setting in which the issue is investigated.

scholarly journals INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET

2020 ◽  
pp. 57-64
Author(s):  
E. A. Bykova
Keyword(s):  
Pharmaceutical Industry ◽  
Innovation Management ◽  
Innovation Process ◽  
Pharmaceutical Market ◽  
Innovative Development ◽  
Management Mechanism ◽  
Technical Research ◽  
The World ◽  
Domestic Company ◽  
The Russian Federation

The definitions the concepts of “innovations” and “innovation process” have been adduced, general assessment of the position of the Russian Federation in the world in terms of investment in scientific and technical research and developments (R & D) has been given, the most investment areas in terms of the volume of expenditures on scientific and technical research and development (R & D) have been highlighted . Key arguments that justify the need for innovative development of the pharmaceutical industry in Russia have been presented. The state and structure of the pharmaceutical market in Russia have been considered, the factors of transition of the pharmaceutical industry to an innovative course of development have been specified. Clear results of the implementation of the strategy for the development of the pharmaceutical industry until 2020 have been emphasized. Examples of implementation of the innovation management mechanism at the level of a separate domestic company Biocad have been given.

scholarly journals PEDAGOGICAL INNOVATION AND TECHNOLOGY OF CASE-STUDY IN TRAINING ON MANAGEMENT AND MARKETING IN PHARMACY IN THE PROCESS OF FORMATION OF PROFESSIONAL COMPETITION

2021 ◽  
pp. 63-68
Author(s):  
G. VOSKOBOINIKOVA ◽  
V. DOVDGUK ◽  
L. KONOVALOVA
Keyword(s):  
Higher Education ◽  
Labor Market ◽  
Pharmaceutical Industry ◽  
European Integration ◽  
Professional Training ◽  
Professional Competence ◽  
Higher Education Institutions ◽  
Pharmaceutical Market ◽  
Pedagogical Innovation

The article substantiates the application of pedagogical innovation and case-study technology in training in management and marketing in pharmacy in the process of forming the professional competence of future masters in higher education institutions. Professional training of masters of the pharmaceutical industry in higher education institutions should be aimed at ensuring the formation of their professional competence for successful professional self-realization of the individual in today's labor market. The strategic landmark of our country's development - European integration determines the modernization of Ukraine's higher education system, which includes modernization processes and improvement of higher pharmaceutical education, in accordance with social conditionality and labor market demands, optimization of integration processes, adaptation to the European pharmaceutical market and labor market. New demands of the pharmaceutical market lead to the improvement of the system of professional training of future specialists in the pharmaceutical industry in higher education institutions on the basis of the competence approach and their readiness to perform professional competencies. It is established that the modernization of educational processes in the training of future masters of the pharmaceutical industry requires the introduction of sectoral and educational innovations and technologies that will ensure their competitiveness in the modern labor market and further development of the pharmaceutical industry in terms of European integration. Cases of professional-pharmaceutical model situations and level diagnostic packages of tests have been developed, which in complex use provides an opportunity to assess students' academic achievements and diagnose the level of professional competence, readiness to implement professional competencies in management and marketing in pharmacy. A systematic analysis and differential assessment of the formation of professional competence and readiness to implement professional pharmaceutical competencies and research competencies of future masters in applied industry research in management and marketing in pharmacy based on students solving professional-pharmaceutical model situations and test tasks diagnostic packages.

Determining the structure of pharmaceutical industry in Iran

2019 ◽  
Vol 13 (1) ◽  
pp. 101-115
Author(s):  
Sara Emamgholipour ◽  
Lotfali Agheli
Keyword(s):  
Pharmaceutical Industry ◽  
Economies Of Scale ◽  
Monopolistic Competition ◽  
Pharmaceutical Market ◽  
Data Availability ◽  
Market Demand ◽  
Firm Level ◽  
Content Type ◽  
Measure Concentration ◽  
Pharmaceutical Industries

Purpose As the pharmaceutical industry is one of the key sectors of the health-care system, the identification of its structure is of particular importance. This paper aims to determine the structure of the pharmaceutical industry in Iran to provide appropriate solutions for pricing and regulation by policymakers. Iran is a growing pharmaceutical market with over $4bn in sales, so the supply side needs to be examined to meet the domestic consumption. Design/methodology/approach This research is a descriptive and retrospective analytical study which examines the Iranian pharmaceutical industry through library studies and using pharmaceutical data of the country’s Food and Drug Administration during 1992-2016. Due to data availability in firm level, the concentration ratio of N leading firms and the Herfindahl–Hirschman index are used to measure the concentration of the pharmaceutical market in 2014 and 2016. Findings The results show that pharmaceutical manufacturing, importing companies and distributing companies play roles in monopolistic competition market, loose oligopoly market and oligopoly market, respectively. For all companies, the magnitudes of Herfindahl–Hirschman indices indicate non-competitive settings. As a result, these companies set their own prices, and market demand affects their sales. In addition, demand for medicines is shaped in the form of supply-induced demand. Research limitations/implications This research was accomplished with no computational limitation. However, it was confined to only one country, one industry and the mentioned period of study. Practical implications The pharmaceutical manufacturers have no influence on medicine prices, and government pricing regulations lessen the market power of such market agents. However, the easy entry to and exit from market stimulate producers to participate in manufacturing activities. The pharmaceutical importers may expand their imports in response to entry new actors; however, the new entrants weaken the coordination on pricing decisions. Social implications As pharmaceutical distributers act in an oligopoly market, they can collude, reduce competition and lower the welfare of pharmaceutical consumers. In such conditions, high investment requirements and economies of scale may discourage the entry of new firms. Originality/value Although there are various studies on market structure in non-pharmaceutical industries, this study is a new effort to measure concentration in the Iranian pharmaceutical market and to determine its structure.

scholarly journals Co-Creation as the Solution to Sustainability Challenges in the Greenhouse Horticultural Industry: The Importance of a Structured Innovation Management Process

2021 ◽  
Vol 13 (13) ◽  
pp. 7149
Author(s):  
Ingrid Moons ◽  
Kristien Daems ◽  
Lorens L. J. Van de Velde
Keyword(s):  
Innovation Management ◽  
Relationship Management ◽  
High Tech ◽  
Innovation Development ◽  
Creation Process ◽  
Management Literature ◽  
Sustainability Challenges ◽  
Depth Interviews ◽  
Stakeholder Relationship

Sustainable innovations try to resolve complex challenges related to climate change. Co-creation with diverse stakeholders in innovation networks opens opportunities to successfully develop and implement sustainable innovations. However, collaboration between heterogeneous partners poses challenges at the level of stakeholder relationship management that affect the progress of innovation development. This study’s purpose is to investigate how co-creation processes that develop sustainable and climate-neutral high-tech innovations in the greenhouse horticultural industry should be structured and how stakeholder relationship management affects the progress of innovation development. Design methodology is linked with innovation management literature. A case study observed seven innovation trajectories that developed energy saving and climate-neutral growing techniques in the greenhouse horticultural industry in Flanders (Belgium) and The Netherlands over a period of three years. In-depth interviews (n = 13) were conducted to have the partners reflect on the co-creation process. Results show that co-creation management should focus on team composition, partner alignment and transparent communication about intentions, expectations and role division throughout the process. The initial stages of a co-creation process are crucial for context mapping and creation of team cohesion and do affect the subsequent stages in the process. Besides, in sustainable high-tech contexts, co-creation facilitators are faced with the need for technical knowledge and skills.

INTERNATIONAL CORPORATE ENTREPRENEURSHIP WITH BORN GLOBAL SPIN-ALONG VENTURES — A CROSS-CASE ANALYSIS OF TELEKOM INNOVATION LABORATORIES' VENTURE PORTFOLIO

2014 ◽  
Vol 18 (03) ◽  
pp. 1440007 ◽  
Author(s):  
SARAH MAHDJOUR ◽  
SEBASTIAN FISCHER
Keyword(s):  
Innovation Management ◽  
Special Kind ◽  
Corporate Entrepreneurship ◽  
Domestic Market ◽  
Perceived Threat ◽  
Study Approach ◽  
Multiple Case ◽  
Early Internationalisation ◽  
Cross Case Analysis

This study investigates a special kind of corporate ventures, so called spin-along ventures, and their motivations to internationalise early. Insights are built from a multiple case study approach, investigating the spin-along program of Telekom Innovation Laboratories (T-Labs). Our results show that early internationalisation can avoid or reduce challenges that spin-alongs face when entering the domestic market. Four major motivations for early internationalisation could be identified: (1) avoid termination based on the parent's perceived threat of cannibalisation of existing products, (2) enable a venture's collaboration with competitors, (3) overcome restrictions of parental assets in the domestic market, and (4) address markets that offer greater chances for success than the domestic market does. Based on our findings we derive concrete implications for practitioners and academics in the field of innovation management.

Sign in / Sign up

Export Citation Format

Share Document